Key result
Both an autoimmune response and a parasite-driven immune response involving inflammatory cytokines and chemokines may play a role in generating the heart lesions leading to Chagas disease cardiomyopathy.
This review highlights that both autoimmune and parasite-driven immune responses contribute to the pathogenesis of Chagas disease cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Dual immune mechanisms may drive Chagas cardiomyopathy; leaves open targeted therapies pending prospective trials.
Chagas disease continues to be a significant public health problem, as ca. 10 million people are still infected with T. cruzi in Latin America. Decades after primary infection, 30% of individuals can develop a form of chronic inflammatory cardiomyopathy known as Chagas disease cardiomyopathy (CCC). Data from both murine models and human studies support the view that an autoimmune response as well as a parasite-driven immune response involving inflammatory cytokines and chemokines may both play a role in generating the heart lesions leading to CCC. This review aims to summarize recent advances in the understanding of the immunopathogenesis of Chagas disease cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Bilate et al. (2008) conducted a review in Chagas disease cardiomyopathy. Both an autoimmune response and a parasite-driven immune response involving inflammatory cytokines and chemokines may play a role in generating the heart lesions leading to Chagas disease cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: